ABCL Free Cash Flow
Operating cash flow less capital expenditures — the cash a business keeps after funding itself.
Free Cash Flow
Latest: $24M (2026Q2)
| Period | Value |
|---|---|
| 2023Q1 | −$59M |
| 2023Q2 | −$7M |
| 2023Q3 | −$20M |
| 2023Q4 | −$34M |
| 2024Q1 | −$66M |
| 2024Q2 | −$50M |
| 2024Q3 | −$47M |
| 2024Q4 | −$24M |
| 2025Q1 | −$22M |
| 2025Q2 | −$46M |
| 2025Q3 | −$62M |
| 2025Q4 | −$45M |
| 2026Q1 | −$37M |
| 2026Q2 | $24M |
Other Indicators
Other ABCL Charts
More quarter-by-quarter fundamentals for AbCellera Biologics Inc.
1 / 8
Revenue
EPS
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Rule of 40
Healthcare Comparison
1 / 3
Free Cash Flow
Free Cash Flow
Free Cash Flow
Latest Free Cash Flow: $24M (2026Q2).
Across the 14 quarters from 2023Q1 to 2026Q2, Free Cash Flow ranged from −$66M in 2024Q1 to $24M in 2026Q2.